Literature DB >> 8993497

Chemistry of the camptothecins in the bloodstream. Drug stabilization and optimization of activity.

T G Burke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8993497     DOI: 10.1111/j.1749-6632.1996.tb26373.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Design, synthesis and potent cytotoxic activity of novel 7-(N-[(substituted-sulfonyl)piperazinyl]-methyl)-camptothecin derivatives.

Authors:  Gao-Xiang Zhu; Pi-Le Cheng; Masuo Goto; Na Zhang; Susan L Morris-Natschke; Kan-Yen Hsieh; Guan-Zhou Yang; Qian-Ru Yang; Ying-Qian Liu; Hai-Le Chen; Xiao-Shuai Zhang; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2017-02-28       Impact factor: 2.823

2.  Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.

Authors:  Nilesh A Patankar; Dawn Waterhouse; Dita Strutt; Malathi Anantha; Marcel B Bally
Journal:  Invest New Drugs       Date:  2012-05-22       Impact factor: 3.850

3.  Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.

Authors:  Peichen Pan; Jiean Chen; Xijian Li; Miyang Li; Huidong Yu; Jean J Zhao; Jing Ni; Xuwen Wang; Huiyong Sun; Sheng Tian; Feng Zhu; Feng Liu; Yong Huang; Tingjun Hou
Journal:  J Med Chem       Date:  2018-09-27       Impact factor: 7.446

4.  Metabolic difference of CZ48 in human and mouse liver microsomes.

Authors:  Xing Liu; Albert DeJesus; Zhisong Cao; Dana Vardeman; Beppino Giovanella
Journal:  Int J Mol Sci       Date:  2012-05-08       Impact factor: 6.208

5.  A novel core-shell lipid nanoparticle for improving oral administration of water soluble chemotherapeutic agents: inhibited intestinal hydrolysis and enhanced lymphatic absorption.

Authors:  Tao Wang; Liao Shen; Zhen Zhang; Haiyan Li; Ri Huang; Yadan Zhang; Dongqin Quan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.